NCT06017921View on ClinicalTrials.gov

Effect of Eszopiclone on Adherence to CPAP and Severity of Insomnia in Patients With COMISA

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 24, 2023

Primary Completion Date

March 20, 2025

Study Completion Date

December 20, 2025

Conditions
Obstructive Sleep ApneaInsomnia
Interventions
DRUG

Eszopiclone 3 mg

Patients starting CPAP treatment will be randomized to either Eszopiclone or Placebo arm

DRUG

Placebo

Patients starting CPAP treatment will be randomized to either Eszopiclone or Placebo arm

Trial Locations (1)

55

RECRUITING

Sleep Laboratory, Heart Institute, Pulmonary Division, Hospital das Clínicas da Universidade de São Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER